Abstract
Summary: Barth syndrome, a rare X-linked genetic disorder, features early-onset cardiomyopathy. The causal gene, TAFAZZIN , encodes a transacylase that mediates acyl chain remodeling of cardiolipin, a critical phospholipid in the inner mitochondrial membrane. While Barth syndrome exhibits hallmark cardiolipin abnormalities, the precise mechanisms linking TAFAZZIN deficiency and disturbed cardiolipin metabolism to progressive cardiac dysfunction remain unclear. In this study, we modeled Barth syndrome cardiomyopathy in human induced pluripotent stem cell-derived cardiomyocytes with in vitro maturation treatments that simulate heart developmental stimuli. We found that cardiomyocyte maturation involves progressive cristae dynamics associated with protein and lipid alterations in the inner mitochondrial membrane. TAFAZZIN-deficient cardiomyocytes fail to adapt to the developmental stimuli, resulting in damaged cristae, compromised mitochondrial respiration, and cardiomyocyte dysfunction. These results demonstrate that TAFAZZIN deficiency perturbs functional and structural development of mitochondria, which may contribute to mitochondrial dysfunction and associated childhood progression to cardiomyopathy in Barth syndrome.
All Related Versions
Funding Information
  • American Heart Association (828058)
  • Magic That Matters Fund
  • The Johns Hopkins University Catalyst and Mirowski Awards
  • Maryland Stem Cell Research Fund (2023- MSCRFL-5984)
  • Maryland Stem Cell Research Fund (2024-MSRFD-6393)
  • Austrian Science Fund (10.55776/P33333)
  • Austrian Science Fund (10.55776/P34574)
  • Austrian Science Fund (10.55776/FG-15)

This publication has 71 references indexed in Scilit: